Literature DB >> 10073183

Fulminant hepatic failure.

A O Shakil1, G V Mazariegos, D J Kramer.   

Abstract

Fulminant hepatic failure is a disease of varied causes and a high mortality rate. A sudden onset, jaundice, hepatic encephalopathy, and multiorgan failure are the hallmarks of this syndrome. The management of patients with FHF requires a multidisciplinary approach and intense monitoring. The availability of liver transplantation has provided the means to rescue such patients from near-certain death. Early prognostication and timely availability of donor livers are requirements for a successful outcome. The development of effective artificial liver support devices may greatly prolong the window of opportunity to provide a donor liver, or alternatively, to allow the native liver to regenerate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073183     DOI: 10.1016/s0039-6109(05)70008-6

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Liver transplantation and artificial liver support in fulminant hepatic failure.

Authors:  X F Zhu; G H Chen; X S He; M Q Lu; G D Wang; C J Cai; Y Yang; J F Huang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Systematic review: extracorporeal bio-artificial liver-support system for liver failure.

Authors:  Jinyang Gu; Xiaolei Shi; Haozhen Ren; Qingxiang Xu; Jun Wang; Jiangqiang Xiao; Yitao Ding
Journal:  Hepatol Int       Date:  2012-03-28       Impact factor: 6.047

3.  Metastatic small-cell lung cancer presenting as fulminant hepatic failure.

Authors:  Elaine Ke; Juan Diego Ortiz Gomez; Kevin Tang; Krishna B Sriram
Journal:  BMJ Case Rep       Date:  2013-04-23

4.  Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

Authors:  John F Patzer
Journal:  Artif Organs       Date:  2008-07       Impact factor: 3.094

5.  A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice.

Authors:  Bo Feng; Sheng Ming Wu; Sa Lv; Feng Liu; Hong Song Chen; Yan Gao; Fang Ting Dong; Lai Wei
Journal:  BMC Gastroenterol       Date:  2009-12-30       Impact factor: 3.067

6.  Acute liver failure secondary to metastatic medullary thyroid cancer.

Authors:  Emmanuel C Gorospe; Jemilat Badamas
Journal:  Case Reports Hepatol       Date:  2012-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.